Patients will be assigned to one of three treatment groups. Study medication is administered over a 52 week study duration.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT00152386?cond=%22Arthritis%22&lup_s=08/23/2013&lup_d=30
By ClinicalTrial.gov Patients will be assigned to one of three treatment groups. Study medication is administered over a 52 week study duration.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT00152386?cond=%22Arthritis%22&lup_s=08/23/2013&lup_d=30
The independent gateway for the orthopaedic community. Connecting professionals and patients since 1999.